Publications of Nicolas DELHOUGNE
Bookmark and Share    
Full Text
See detailApproche critique du traitement prolonge par inhibiteurs de la pompe a protons chez les personnes agees.
DELHOUGNE, Nicolas ULiege; Allepaerts, Sophie ULiege; GAST, Pierrette ULiege et al

in Revue medicale de Liege (2020), 75(1), 10-16

Proton pump inhibitors (PPI) are drugs frequently used for gastric acid-induced conditions. Their use is constantly increasing and due to the apparent absence of side-effects, the treatment is not ... [more ▼]

Proton pump inhibitors (PPI) are drugs frequently used for gastric acid-induced conditions. Their use is constantly increasing and due to the apparent absence of side-effects, the treatment is not reassessed, even for the elderly. However, there are many cases of misprescribing while concerns about some side-effects are rising. Old people are weakened by their particular homeostasis and their associated medical conditions. Therefore, it seems useful to particularly insist on side-effects of the PPI, their indications and the ways of withdrawal, first of all for the elderly. [less ▲]

Detailed reference viewed: 56 (7 ULiège)
Full Text
See detailMaladies inflammatoires chroniques de l'intestin et phenomenes thromboemboliques veineux.
DELHOUGNE, Nicolas ULiege; COLARD, Arnaud ULiege; Louis, Edouard ULiege

in Revue Médicale de Liège (2018), 73(9), 462-467

Inflammatory Bowel Diseases (IBD) are associated with lots of extra-intestinal complications. Among them, venous and arterial thromboembolisms lead to high rates of morbidity and mortality. They often ... [more ▼]

Inflammatory Bowel Diseases (IBD) are associated with lots of extra-intestinal complications. Among them, venous and arterial thromboembolisms lead to high rates of morbidity and mortality. They often occur during an IBD flare and seem to be mostly provoked by acquired factors. The prevention mainly resorts to heparin, which is not used enough in spite of its effectiveness. Its indications have recently been upgraded to outpatients. In this review, we describe the epidemiological and aetiological features of these manifestations, as well as their prevention and management. Only venous thromboembolisms are considered. [less ▲]

Detailed reference viewed: 28 (3 ULiège)